Skip to Main Content

Paper Details

Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial.
Crit Care
3
2023
Author NameAffiliation
Nicole P JuffermansOLVG Hospital Location Oost
Nicole P JuffermansErasmus University
Marcus J SchultzAmsterdam UMC Location University of Amsterdam
Marcus J SchultzMahidol Oxford Tropical Medicine Research Unit (MORU), Mahidol University
Marcus J SchultzUniversity of Oxford
Marcus J SchultzDepartment of Research and Development
Lieuwe D J BosAmsterdam UMC Location University of Amsterdam
Lieuwe D J BosAmsterdam University Medical Centers
  • 1 - 8

Datasets

Release 1.2